{"name":"Resolvyx Pharmaceuticals, Inc","slug":"resolvyx-pharmaceuticals-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxNRzhhTUx1aEFSTWxkZTkxWE5zeE5US3F3cXJBY1p5UXNaS1VpZmh6S0VUR1liYnJaclloOERDanFBXzkyTEFfQmtlLXgtOTBwczZKeHdRZmVXWktVcXJ3dnJNdWtkN2ZkTmxaVU10dzM2ME81M0R5Z2pUTnQtZ1d3TVdxaVVndkVxVmNaU2Q3blEyM05UaTBKdlBTQmhySWFPdmYzU09yRHlJUQ?oc=5","date":"2014-06-04","type":"regulatory","source":"Nutritional Outlook","summary":"FDA Approves Three More Omega-3 Drugs. Is This Good or Bad News for Supplements? - Nutritional Outlook","headline":"FDA Approves Three More Omega-3 Drugs. Is This Good or Bad News for Supplements?","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxQdUFtVnc1dERxWU95SlNGYmhBdzJmVy1zbzdRVXFMXzVHY01uT1BkQVd3NU5aMElRMjFrOVBjLXAwekw0eUIxUktrMU9pc0V3N0ZfeFZXYmhiNTlEay1HUUQ5N1lIbWs3NnY1WDFtcmpNZlFEN01zT3FseWtDREpfcWZTVy1UcTMzcG1Id2w0MENLZVU2?oc=5","date":"2013-07-04","type":"pipeline","source":"PMLiVE","summary":"Warp Drive Bio names Gregory Verdine as CEO - PMLiVE","headline":"Warp Drive Bio names Gregory Verdine as CEO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiYEFVX3lxTE04NmJfOFFtbDhROEVuMnBaWGh1bG9wNXZiU29qcE5wbGIxWXFRTWZyQjFmN0I3NlRBVG9VV244b2YxbDlReG9XNEhvLUVUaFIwY1hHMWVzbk11Y3JiZnBWRg?oc=5","date":"2010-10-11","type":"pipeline","source":"Contract Pharma","summary":"Shire - Contract Pharma","headline":"Shire","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}